Radiopharmacy
Cancer radiopharmaceuticals detect the abundance of tumor-specific targets that differentiate cancerous tissue from healthy tissue. At City of Hope®, we use radiopharmaceuticals to direct radiation precisely at tumor cells, enhancing diagnostics and therapies.
Duo-licensed by the California State Board of Pharmacy, our on-site dispensing and manufacturing radiopharmacy brings lifesaving radiopharmaceuticals for preclinical and clinical studies from bench to bedside. Key features include:
- Novel probe development
- State-of-the-art facility for radiolabeling and radiosynthesis
- PET and SPECT and therapeutic radiopharmaceutical quality control and assurance
City of Hope received top designation from the Society of Nuclear Medicine and Molecular Imaging for our radiopharmaceutical therapy program. This recognition highlights our commitment to advancing the field of radiopharmaceutical therapy and our dedication to providing the highest quality of care to our patients.